CELLULOSE, MICROCRYSTALLINE, COLLOIDAL SILICON DIOXIDE, CROSCARMELLOSE SODIUM, MAGNESIUM STEARATE, DARIDOREXANT
SEDA
Approved small_molecule active
Quick answer
CELLULOSE, MICROCRYSTALLINE, COLLOIDAL SILICON DIOXIDE, CROSCARMELLOSE SODIUM, MAGNESIUM STEARATE, DARIDOREXANT for Patients with major depressive episode and moderate to severe insomnia disorder is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Patients with major depressive episode and moderate to severe insomnia disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- active